NASDAQ
Viridian Therapeutics, Inc. (VRDN)
♥ 439 Thanks from members
Viridian Therapeutics, Inc. (VRDN) is experiencing mixed market sentiment, marked by a recent 22% cut in analyst revenue estimates, intermittent selling pressure, and volatile price action testing key technical support levels.